BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 25393773)

  • 21. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
    Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
    Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
    Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting cardiac involvement with magnetic resonance in patients with active eosinophilic granulomatosis with polyangiitis.
    Yune S; Choi DC; Lee BJ; Lee JY; Jeon ES; Kim SM; Choe YH
    Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():155-62. PubMed ID: 26831057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis].
    Zhu KB; Cheng ZW; Tian Z; Zhao DC; Liu YT; Lin X; Chen TB; Xie HZ; Zeng Y; Fang LG; Jiang XC; Cui QC; Fang Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):915-9. PubMed ID: 22321275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging.
    Te Rijdt WP; Ten Sande JN; Gorter TM; van der Zwaag PA; van Rijsingen IA; Boekholdt SM; van Tintelen JP; van Haelst PL; Planken RN; de Boer RA; Suurmeijer AJH; van Veldhuisen DJ; Wilde AAM; Willems TP; van Dessel PFHM; van den Berg MP
    Eur Heart J Cardiovasc Imaging; 2019 Jan; 20(1):92-100. PubMed ID: 29635323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of myocardial fibrosis on left ventricular torsion and twist in patients with non-ischemic dilated cardiomyopathy.
    Karaahmet T; Gürel E; Tigen K; Güler A; Dündar C; Fotbolcu H; Basaran Y
    Cardiol J; 2013; 20(3):276-86. PubMed ID: 23788302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Echocardiographic Measures of Left Ventricular Function in Patients with Duchenne Muscular Dystrophy: Assessment of Reproducibility and Comparison to Cardiac Magnetic Resonance Imaging.
    Soslow JH; Xu M; Slaughter JC; Stanley M; Crum K; Markham LW; Parra DA
    J Am Soc Echocardiogr; 2016 Oct; 29(10):983-991. PubMed ID: 27544870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis.
    Pozo E; Kanwar A; Deochand R; Castellano JM; Naib T; Pazos-López P; Osman K; Cham M; Narula J; Fuster V; Sanz J
    Heart; 2014 Nov; 100(21):1688-95. PubMed ID: 25012950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis].
    Cui Q; Yu J; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1538-1541. PubMed ID: 32029045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging.
    Lang SM; Shugh S; Mazur W; Sticka JJ; Rattan MS; Jefferies JL; Taylor MD
    Pediatr Cardiol; 2015 Oct; 36(7):1495-501. PubMed ID: 25976773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
    Karamitsos TD; Piechnik SK; Banypersad SM; Fontana M; Ntusi NB; Ferreira VM; Whelan CJ; Myerson SG; Robson MD; Hawkins PN; Neubauer S; Moon JC
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):488-97. PubMed ID: 23498672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
    Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Accuracy of Cardiac Magnetic Resonance Imaging in the Evaluation of Newly Diagnosed Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Won E; Donnino R; Srichai MB; Sedlis SP; Feit F; Rolnitzky L; Miller LH; Iqbal SN; Axel L; Nguyen B; Slater J; Shah B
    Am J Cardiol; 2015 Oct; 116(7):1082-7. PubMed ID: 26251006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial inflammation on cardiovascular magnetic resonance predicts left ventricular function recovery in children with recent dilated cardiomyopathy.
    Raimondi F; Iserin F; Raisky O; Laux D; Bajolle F; Boudjemline Y; Boddaert N; Bonnet D
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):756-62. PubMed ID: 25711351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.
    Raina S; Lensing SY; Nairooz RS; Pothineni NV; Hakeem A; Bhatti S; Pandey T
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1267-1277. PubMed ID: 27568115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
    Langer C; Schaefer P; Lutz M; Eden M; Hohnhorst M; Harders H; Faber L; Jansen O; Both M; Frey N
    J Comput Assist Tomogr; 2015; 39(5):797-803. PubMed ID: 26125299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.